ClinicalTrials.Veeva

Menu

Does Amniotic Fluid Index Affect the Fetal Cardiac Performance?

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Oligohydramnios
Polyhydramnios

Treatments

Other: Echocardiography

Study type

Observational

Funder types

Other

Identifiers

NCT03277417
HYMC-0037-17

Details and patient eligibility

About

To evaluate and compare fetal cardiac performance by fetal echocardiography and delivery outcome between fetuses with isolated oligohydramnios, normal amniotic fluid and polyhydramnios.

Enrollment

90 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gestational age 24-42 weeks
  • Singleton pregnancies

Exclusion criteria

  • Fetal anatomical or chromosomal abnormality
  • Known fetal cardiac defect
  • Suspected fetal infection
  • Suspected IUGR

Trial design

90 participants in 3 patient groups

Isolated Oligohydramnios
Description:
Fetuses with amniotic fluid index (AFI) equal or less than 5 cm
Treatment:
Other: Echocardiography
Isolated Polyhydramnios
Description:
Fetuses with amniotic fluid index (AFI) more than 25 cm
Treatment:
Other: Echocardiography
Control Group
Description:
Fetuses with normal amount of amniotic fluid
Treatment:
Other: Echocardiography

Trial contacts and locations

1

Loading...

Central trial contact

Rinat Gabbay-Benziv, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems